15:11 11/03/2025
icon facebook icon twitter icon pinterest
Nguồn tham khảo
  1. Vadarlis, A., Antza, C., Bakaloudi, D. R., Doundoulakis, I., Kalopitas, G., Samara, M., Dardavessis, T., Maris, T., & Chourdakis, M. (2020). Systematic review with meta‐analysis: The effect of vitamin E supplementation in adult patients with non‐alcoholic fatty liver disease. Journal of Gastroenterology and Hepatology, 36(2), 311–319. https://doi.org/10.1111/jgh.15221
  2. Ma, C., Han, L., Zhu, Z., Pang, C. H., & Pan, G. (2022). Mineral metabolism and ferroptosis in non-alcoholic fatty liver diseases. Biochemical Pharmacology, 205, 115242. https://doi.org/10.1016/j.bcp.2022.115242
  3. Office of the Commissioner. (2024, March 14). FDA Approves First Treatment for Patients with Liver Scarring Due to Fatty Liver Disease. U.S. Food And Drug Administration. https://www.fda.gov/news-events/press-announcements/fda-approves-first-treatment-patients-liver-scarring-due-fatty-liver-disease
  4. Burtka, A. T. (2024, December 18). Fatty liver and high blood pressure. WebMD. https://www.webmd.com/fatty-liver-disease/high-blood-pressure-and-fatty-liver
  5. Fabbrini, E., Sullivan, S., & Klein, S. (2009). Obesity and nonalcoholic fatty liver disease: Biochemical, metabolic, and clinical implications. Hepatology, 51(2), 679–689. https://doi.org/10.1002/hep.23280
Chủ đề:
Banner quay số ECO Pharma MB

ĐẶT CÂU HỎI